- Home
- KTOS vs SBFM Comparison
KTOS vs SBFM Comparison
Compare KTOS & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTOS
- SBFM
- Stock Information
- Founded
- KTOS 1994
- SBFM 2006
- Country
- KTOS United States
- SBFM United States
- Employees
- KTOS N/A
- SBFM N/A
- Industry
- KTOS Military/Government/Technical
- SBFM Biotechnology: Pharmaceutical Preparations
- Sector
- KTOS Industrials
- SBFM Health Care
- Exchange
- KTOS Nasdaq
- SBFM Nasdaq
- Market Cap
- KTOS N/A
- SBFM 4.9M
- IPO Year
- KTOS 1999
- SBFM N/A
- Fundamental
- Price
- KTOS $32.12
- SBFM $1.35
- Analyst Decision
- KTOS Buy
- SBFM Strong Buy
- Analyst Count
- KTOS 10
- SBFM 1
- Target Price
- KTOS $32.33
- SBFM $15.00
- AVG Volume (30 Days)
- KTOS 2.2M
- SBFM 4.3M
- Earning Date
- KTOS 05-06-2025
- SBFM 05-19-2025
- Dividend Yield
- KTOS N/A
- SBFM N/A
- EPS Growth
- KTOS N/A
- SBFM N/A
- EPS
- KTOS 0.11
- SBFM N/A
- Revenue
- KTOS $1,136,300,000.00
- SBFM $34,874,283.00
- Revenue This Year
- KTOS $15.11
- SBFM $192.48
- Revenue Next Year
- KTOS $15.60
- SBFM N/A
- P/E Ratio
- KTOS $291.79
- SBFM N/A
- Revenue Growth
- KTOS 9.56
- SBFM 44.75
- 52 Week Low
- KTOS $17.05
- SBFM $1.17
- 52 Week High
- KTOS $35.66
- SBFM $33.60
- Technical
- Relative Strength Index (RSI)
- KTOS 54.56
- SBFM 34.08
- Support Level
- KTOS $31.48
- SBFM $1.17
- Resistance Level
- KTOS $33.94
- SBFM $1.59
- Average True Range (ATR)
- KTOS 1.88
- SBFM 0.33
- MACD
- KTOS 0.11
- SBFM -0.01
- Stochastic Oscillator
- KTOS 77.70
- SBFM 6.63
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.